Clinical Trials Sponsored by NRG Oncology

Total 4577 results

Taiho Oncology, Inc.

Completed

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

Advanced Solid Tumors

United States, Czechia, Serbia
Clovis Oncology, Inc.

Terminated

Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States, Korea, Republic of, Germany, Taiwan, Australia, Hong Kong, Netherlands, Spain, France, United Kingdom, Canada, Switzerland
Taiho Oncology, Inc.

Completed

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment

Advanced Solid Tumors

United States
Clovis Oncology, Inc.

Terminated

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Estrogen Receptor Positive | Triple Negative | HER2 | HER2 Positive | MBC | ER

United States
Celyad Oncology SA

Unknown

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases (SHRINK)

Colon Cancer Liver Metastasis

Belgium
Octimet Oncology N.V.

Terminated

OMO-1 in Solid Malignancies

Neoplasms

France, United Kingdom, Netherlands, United States, Belgium
Taiho Oncology, Inc.

Terminated

Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Taiho Oncology, Inc.

Terminated

An Investigation of TAS-119 Monotherapy

Advanced Solid Tumors

Italy, Spain, United States, Netherlands, United Kingdom
Taiho Oncology, Inc.

Completed

A Trial of TAS-114 in Combination With S-1

Advanced Solid Tumors

France, Belgium, Italy, Switzerland
Maastricht Radiation Oncology

Completed

Exploratory Study on Therapy for Breath Hold in Radiotherapy

Breast Cancer | Lung Cancer

Netherlands
Taiho Oncology, Inc.

Completed

A Study of TAS-116 in Patients With Solid Tumors

Advanced Solid Tumors

United States, United Kingdom, Italy
Maastricht Radiation Oncology

Completed

SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC lung)

Lung Cancer

Netherlands
Clovis Oncology, Inc.

Completed

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

United States
Maastricht Radiation Oncology

Completed

Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

Breast Cancer

Netherlands
Sierra Oncology, Inc.

Terminated

Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

United States
Sierra Oncology, Inc.

Terminated

Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)

EGFR Mutated EGFR TKI Naive Metastatic NSCLC

United States
Sierra Oncology, Inc.

Completed

Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)

Primary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis

United States, Canada, Australia
Clovis Oncology, Inc.

No longer available

Rociletinib (CO-1686) USA Expanded Access Program

Non-small Cell Lung Cancer

United States
Maastricht Radiation Oncology

Completed

Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Netherlands
Celyad Oncology SA

Completed

Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure. (CHART-1)

Heart Failure

Spain, Israel, Belgium, Switzerland, Italy, Bulgaria, Hungary, Poland, Serbia
Maastricht Radiation Oncology

Completed

Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases

Metastases, Neoplasm

Netherlands
Taiho Oncology, Inc.

Completed

A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.

Advanced Gastrointestinal Tumors

United States
Gdynia Oncology Center

Suspended

Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer

Malnutrition | Ovarian Epithelial Cancer | Ascites

Poland
Vector Oncology
GlaxoSmithKline

Completed

Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors

Gynecologic Tumors

United States
Pantarhei Oncology B.V.

Completed

Evaluation of Safety and Efficacy of Estetrol in Healthy Men

Prostatic Neoplasms

Netherlands
Maastricht Radiation Oncology

Completed

PET With [18F]HX4 in Head and Neck Cancer

Cancer of the Head and Neck

Netherlands
Maastricht Radiation Oncology

Terminated

Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients

Esophageal Cancer

Netherlands
Taiho Oncology, Inc.

Completed

Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors

Advanced Solid Tumors (Excluding Breast Cancer)

United States
Light Sciences Oncology

Completed

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Neoplasm Metastasis | Colorectal Neoplasms | Liver Metastases | Neoplasm Recurrence, Local

Sweden, India, Austria, Serbia, Germany, Romania, Croatia, Bosnia and Herzegovina, Italy, Latvia, Poland, Russian Federation, Ukraine
OvaGene Oncology, Inc.

Unknown

DNA Single Nucleotide Polymorphisms as Predictors of Toxicity

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

United States
Maastricht Radiation Oncology

Completed

PET-CT Based Radiotherapy in Esophageal Cancer Patients

Esophageal Neoplasms

Netherlands
Genus Oncology, LLC

Completed

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas

Solid Tumors

United States
Oncology Specialists, S.C.

Completed

Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era

Non-Hodgkin's Lymphoma
Clovis Oncology, Inc.

Terminated

A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin

Lung Cancer | Solid Tumor | Non-small-cell Lung Cancer

United States, United Kingdom
Light Sciences Oncology

Completed

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Glioma | Glioblastoma Multiforme | Anaplastic Astrocytoma

Serbia
Taiho Oncology, Inc.

Completed

A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

Tumors

United States
Taiho Oncology, Inc.

Completed

Evaluating Patients With Impaired Hepatic Function

Impaired Hepatic Function

United States
Maastricht Radiation Oncology

Completed

HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy

Non-Small-Cell Lung Carcinoma

Netherlands
Oncology Specialties, Alabama

Terminated

Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

Pulmonary Neoplasms

United States
CRG UZ Brussel

Active, not recruiting

Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles (REMODEL)

Infertility, Female | Frozen Embryo Transfer | Hormone Replacement Therapy | Dydrogesterone

Belgium
Hellenic Cooperative Oncology Group
Hellenic Society of Medical Oncology

Active, not recruiting

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

Metastatic Breast Cancer

Greece
Radiation Therapy Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest...

Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Head and Neck Cancer

United States, South Africa
Oncology Institute of Southern Switzerland
Institute of Oncology Research

Recruiting

The Immune Landscape of Epithelial Ovarian Cancer (IOSI-GYNE-001)

Epithelial Ovarian Cancer

Switzerland
Gynecologic Oncology Trial & Investigation Consortium
Japanese Gynecologic Oncology Group

Completed

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial (iPocc)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma

Japan, United States, Hong Kong, Korea, Republic of, New Zealand, Singapore
Radiation Therapy Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest...

Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx

Head and Neck Cancer

United States, South Africa
Radiation Therapy Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest...

Completed

Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas

Pancreatic Cancer

United States, Canada
European Institute of Oncology

Not yet recruiting

Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy

Breast Cancer | Neuropathy;Peripheral

Italy
European Institute of Oncology

Recruiting

Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study (MIMETIC)

Adenocarcinoma

Italy
European Institute of Oncology

Recruiting

Study Evaluating Occupational Exposure to Antineoplastic Drugs (BRIC)

Cytotoxicity

Italy
European Institute of Oncology

Recruiting

YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. (YOUNGSTER)

Adenocarcinoma | Neuroendocrine Neoplasm

Italy

Clinical Trials Sponsored by NRG Oncology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations